WallStreetZenWallStreetZen

NASDAQ: RIGL
Rigel Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RIGL

Based on 3 analysts offering 12 month price targets for Rigel Pharmaceuticals Inc

Min Forecast
$38.00+43.4%
Avg Forecast
$45.67+72.33%
Max Forecast
$57.00+115.09%

Should I buy or sell RIGL stock?

Based on 3 analysts offering ratings for Rigel Pharmaceuticals Inc.

Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RIGL's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates RIGL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their RIGL stock forecasts and price targets.

RIGL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-05
lockedlocked$00.00+00.00%2025-11-05
lockedlocked$00.00+00.00%2025-10-08

1 of 1

Forecast return on equity

Is RIGL forecast to generate an efficient return?

Company
22.77%
Industry
67.34%
Market
179.42%
RIGL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RIGL forecast to generate an efficient return on assets?

Company
17.35%
Industry
32.1%
RIGL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RIGL earnings per share forecast

What is RIGL's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$4.14-79.7%
Avg 2 year Forecast
$4.93-75.85%
Avg 3 year Forecast
$4.98-75.59%
RIGL's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

RIGL revenue forecast

What is RIGL's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$289.8M-1.52%
Avg 2 year Forecast
$326.8M+11.03%
Avg 3 year Forecast
$362.7M+23.25%
RIGL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RIGL earnings growth forecast

How is RIGL forecast to perform vs Biotechnology companies and vs the US market?

Company
-36.93%
Industry
11.77%
Market
35.92%
RIGL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
RIGL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
RIGL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

RIGL revenue growth forecast

How is RIGL forecast to perform vs Biotechnology companies and vs the US market?

Company
7.23%
Industry
35.8%
Market
13.37%
RIGL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RIGL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RIGL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RIGL$26.50$45.67+72.33%Buy
ENGN$7.31$21.00+187.28%Buy
LRMR$4.68$13.75+193.80%Strong Buy
PRTA$8.82$24.25+174.94%Buy
VSTM$5.39$18.50+243.23%Strong Buy
View Top Biotech Stocks

Rigel Pharmaceuticals Stock Forecast FAQ

Is Rigel Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: RIGL) stock is to Buy RIGL stock.

Out of 3 analysts, 1 (33.33%) are recommending RIGL as a Strong Buy, 1 (33.33%) are recommending RIGL as a Buy, 1 (33.33%) are recommending RIGL as a Hold, 0 (0%) are recommending RIGL as a Sell, and 0 (0%) are recommending RIGL as a Strong Sell.

If you're new to stock investing, here's how to buy Rigel Pharmaceuticals stock.

What is RIGL's earnings growth forecast for 2026-2028?

(NASDAQ: RIGL) Rigel Pharmaceuticals's forecast annual earnings growth rate of -36.93% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.77%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.92%.

Rigel Pharmaceuticals's earnings in 2026 is $367,024,000.On average, 7 Wall Street analysts forecast RIGL's earnings for 2026 to be $76,506,468, with the lowest RIGL earnings forecast at $56,845,516, and the highest RIGL earnings forecast at $96,595,997. On average, 7 Wall Street analysts forecast RIGL's earnings for 2027 to be $91,028,195, with the lowest RIGL earnings forecast at $57,750,699, and the highest RIGL earnings forecast at $141,286,193.

In 2028, RIGL is forecast to generate $91,999,882 in earnings, with the lowest earnings forecast at $40,190,142 and the highest earnings forecast at $143,342,252.

What is RIGL's revenue growth forecast for 2026-2028?

(NASDAQ: RIGL) Rigel Pharmaceuticals's forecast annual revenue growth rate of 7.23% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.37%.

Rigel Pharmaceuticals's revenue in 2026 is $294,282,000.On average, 7 Wall Street analysts forecast RIGL's revenue for 2026 to be $5,353,697,805, with the lowest RIGL revenue forecast at $5,078,078,706, and the highest RIGL revenue forecast at $5,572,789,127. On average, 7 Wall Street analysts forecast RIGL's revenue for 2027 to be $6,036,095,228, with the lowest RIGL revenue forecast at $5,554,685,460, and the highest RIGL revenue forecast at $6,872,373,823.

In 2028, RIGL is forecast to generate $6,700,204,251 in revenue, with the lowest revenue forecast at $5,976,057,555 and the highest revenue forecast at $8,439,634,172.

What is RIGL's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: RIGL) forecast ROA is 17.35%, which is lower than the forecast US Biotechnology industry average of 32.1%.

What is RIGL's Price Target?

According to 3 Wall Street analysts that have issued a 1 year RIGL price target, the average RIGL price target is $45.67, with the highest RIGL stock price forecast at $57.00 and the lowest RIGL stock price forecast at $38.00.

On average, Wall Street analysts predict that Rigel Pharmaceuticals's share price could reach $45.67 by Nov 5, 2026. The average Rigel Pharmaceuticals stock price prediction forecasts a potential upside of 72.33% from the current RIGL share price of $26.50.

What is RIGL's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: RIGL) Rigel Pharmaceuticals's current Earnings Per Share (EPS) is $20.40. On average, analysts forecast that RIGL's EPS will be $4.14 for 2026, with the lowest EPS forecast at $3.08, and the highest EPS forecast at $5.23. On average, analysts forecast that RIGL's EPS will be $4.93 for 2027, with the lowest EPS forecast at $3.13, and the highest EPS forecast at $7.65. In 2028, RIGL's EPS is forecast to hit $4.98 (min: $2.18, max: $7.76).

What is RIGL's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: RIGL) forecast ROE is 22.77%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.